Wednesday, November 02, 2016
Tuesday, October 25, 2016
Friday, October 21, 2016
Wednesday, October 19, 2016
Monday, October 17, 2016
Friday, October 14, 2016
Thursday, October 13, 2016
Tuesday, October 11, 2016
Why Stop at Sugary Drinks?
Tax sugary drinks to fight obesity and diabetes, World Health Organization says.
http://www.reuters.com/article/us-health-sugar-idUSKCN12B0ZB
Coke and Pepsi Give Millions to Public Health, Then Lobby Against It.
http://www.nytimes.com/2016/10/10/well/eat/coke-and-pepsi-give-millions-to-public-health-then-lobby-against-it.html?_r=0
http://www.reuters.com/article/us-health-sugar-idUSKCN12B0ZB
Coke and Pepsi Give Millions to Public Health, Then Lobby Against It.
http://www.nytimes.com/2016/10/10/well/eat/coke-and-pepsi-give-millions-to-public-health-then-lobby-against-it.html?_r=0
Friday, October 07, 2016
Tuesday, October 04, 2016
Thursday, September 29, 2016
Tuesday, September 27, 2016
Monsanto Bought Out
Monsanto has accepted Bayer AG’s $66 billion takeover offer, which will make the new entity the largest seed and pesticide company in the world.
If the merger goes through, we’ll be left with just four companies providing 59 percent of the global seeds and 64 percent of the world’s pesticides, which some predict will be a disaster for the global food system.
If the merger goes through, we’ll be left with just four companies providing 59 percent of the global seeds and 64 percent of the world’s pesticides, which some predict will be a disaster for the global food system.
Thursday, September 22, 2016
Wednesday, September 21, 2016
How Top Restaurants Rate on Reducing Use of Antibiotics in Their Meat Supply
Not surprisingly, Panera and Chipotle were rated the best.
http://webiva-downton.s3.amazonaws.com/877/c1/e/9136/1/NRDC_ChainReaction2_ExecSumm.pdf
http://webiva-downton.s3.amazonaws.com/877/c1/e/9136/1/NRDC_ChainReaction2_ExecSumm.pdf
Monday, September 19, 2016
Friday, September 16, 2016
Splenda Naturals: Here We Go!
Due to declining sales of their flagship artificial sweetener, Splenda has produced a rival to Truvia and PureVia.
It has the same ingredients as the other two: stevia extract and erythritol.
They market it as a natural non-caloric sweetener, but as you know now, erythritol is anything but natural.
https://www.splenda.com/naturals
Don't buy into the hype!
It has the same ingredients as the other two: stevia extract and erythritol.
They market it as a natural non-caloric sweetener, but as you know now, erythritol is anything but natural.
https://www.splenda.com/naturals
Don't buy into the hype!
Thursday, September 15, 2016
Huge Lancet Review on Statins Littered With Conflict of Interest
There was a ton of press on statins a few weeks ago. Take any of it with a grain of salt. Look at the conflict of interest with the authors of the study!
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31357-5/fulltext
"Declaration of interests from the authors
JA, CB, LB, RC, JE, RP, DP, and CR work in the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) at the University of Oxford. The CTSU has received research grants from Abbott, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, Schering, and Solvay that are governed by University of Oxford contracts that protect its independence, and it has a staff policy of not taking personal payments from industry (with reimbursement sought only for the costs of travel and accommodation to attend scientific meetings). RC is co-inventor of a genetic test for statin-related myopathy risk, but receives no income from it. DP has participated in advisory meetings for Sanofi related to PCSK9 inhibitor therapy in his previous employment. The CTT Collaboration, which is coordinated by CTSU with colleagues from the University of Sydney, does not receive industry funding. JD has received research grants from, and served as a consultant to, Merck and Pfizer. GDS has twice received travel and accommodation funding and honoraria from Merck; DD receives compensation for serving on data monitoring committees for clinical trials (including of statins) funded by Abbvie, Actelion, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Sanofi, and Teva. NW and ML are inventors of a combination formulation for the prevention of cardiovascular disease that includes a statin, covered by patents licensed to Polypill in which they both hold shares and which owns the website polypill.com. SMac has received research grants for research on statins and polypill development from Bristol-Myers Squibb and BUPA. SMar is co-inventor on a pending patent for a LDL cholesterol estimation method, and has served as an advisor to Sanofi, Regeneron, Quest Diagnostics, Pressed Juicery, and Abbott Nutrition. NP has received research grants and honoraria for participating in advisory meetings and giving lectures from Amgen, Lilly, Menorini, and Merck. PR has received investigator-initiated research grants from Amgen, AstraZeneca, Kowa, Novartis, and Pfizer. PSe has received research grants and honoraria for consultancies from Amgen and Pfizer. LS has undertaken advisory work unrelated to statins for AstraZeneca and GlaxoSmithKline. SY has received a research grant from AstraZeneca through Hamilton Health Sciences. AR declares that George Health Enterprises, the social enterprise arm of The George Institute, has received investment to develop combination products containing statin, aspirin, and blood-pressure-lowering drugs. JS has received grants from the National Health and Medical Research Council, Australia; Bayer Pharmaceuticals; Roche; and Merck Serono. RB, SE, BN, IR, and PSa declare no competing interests."
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31357-5/fulltext
"Declaration of interests from the authors
JA, CB, LB, RC, JE, RP, DP, and CR work in the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) at the University of Oxford. The CTSU has received research grants from Abbott, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, Schering, and Solvay that are governed by University of Oxford contracts that protect its independence, and it has a staff policy of not taking personal payments from industry (with reimbursement sought only for the costs of travel and accommodation to attend scientific meetings). RC is co-inventor of a genetic test for statin-related myopathy risk, but receives no income from it. DP has participated in advisory meetings for Sanofi related to PCSK9 inhibitor therapy in his previous employment. The CTT Collaboration, which is coordinated by CTSU with colleagues from the University of Sydney, does not receive industry funding. JD has received research grants from, and served as a consultant to, Merck and Pfizer. GDS has twice received travel and accommodation funding and honoraria from Merck; DD receives compensation for serving on data monitoring committees for clinical trials (including of statins) funded by Abbvie, Actelion, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Sanofi, and Teva. NW and ML are inventors of a combination formulation for the prevention of cardiovascular disease that includes a statin, covered by patents licensed to Polypill in which they both hold shares and which owns the website polypill.com. SMac has received research grants for research on statins and polypill development from Bristol-Myers Squibb and BUPA. SMar is co-inventor on a pending patent for a LDL cholesterol estimation method, and has served as an advisor to Sanofi, Regeneron, Quest Diagnostics, Pressed Juicery, and Abbott Nutrition. NP has received research grants and honoraria for participating in advisory meetings and giving lectures from Amgen, Lilly, Menorini, and Merck. PR has received investigator-initiated research grants from Amgen, AstraZeneca, Kowa, Novartis, and Pfizer. PSe has received research grants and honoraria for consultancies from Amgen and Pfizer. LS has undertaken advisory work unrelated to statins for AstraZeneca and GlaxoSmithKline. SY has received a research grant from AstraZeneca through Hamilton Health Sciences. AR declares that George Health Enterprises, the social enterprise arm of The George Institute, has received investment to develop combination products containing statin, aspirin, and blood-pressure-lowering drugs. JS has received grants from the National Health and Medical Research Council, Australia; Bayer Pharmaceuticals; Roche; and Merck Serono. RB, SE, BN, IR, and PSa declare no competing interests."
Yucky Federal GMO Bill Becomes Law
Aside from overriding state and local laws, what are some of the DARK Act’s other fundamental deficiencies?
- There is no requirement for on-package labeling of GMO foods.
- As many as 100 million Americans lack the ability to find out product specifics by not being able to access QR codes.
- The biotech-friendly USDA – not the FDA – is charged with creating the law’s actual labeling rules over the next two years.
- The bill leaves totally unclear what will be considered a GMO food and/or ingredient. According to the FDA, most foods typically thought of as being produced or made with GMO ingredients will not be covered by the bill’s narrow definition of genetic engineering. The USDA might raise the threshold for incidental GMO contamination from the currently accepted .09% to as high as 30% while still calling that non-GMO!
- The bill suggests that the USDA harmonize its ultimate definition of genetic engineering with the organic law’s definitions – something that could create a huge loophole into organic’s current strict prohibitions on GMO technology.
Wednesday, September 14, 2016
Monday, September 05, 2016
Friday, September 02, 2016
Wednesday, August 31, 2016
Tuesday, August 30, 2016
Monday, August 29, 2016
Thursday, August 25, 2016
Wednesday, August 24, 2016
Thursday, August 18, 2016
Sugar, Artificial Sweetener Addiction Treatment
Neuroscientists said in a study in PLOS ONE, drugs used to treat nicotine addiction could be used to treat sugar addiction in animals. The study coincides with another paper by the same neuroscientists in Frontiers in Behavioral Neuroscience.
Once and for all, we can admit that long chronic sugar intake can cause eating disorders and impact on behavior.
Excess sugar consumption elevate dopamine levels which control the brain's reward and pleasure centers in a way that is similar to many drugs of abuse including tobacco, cocaine and morphine. After long-term consumption, this leads to the opposite, a reduction in dopamine levels. This leads to higher consumption of sugar to get the same level of reward.
The found that FDA approved drugs like varenicline, a prescription medication trading as Champix which treats nicotine addiction, can work the same way when it comes to sugar cravings.
To the researcher's surprise, the study also found that artificial sweeteners could produce effects similar to those obtained with table sugar.
Once and for all, we can admit that long chronic sugar intake can cause eating disorders and impact on behavior.
Excess sugar consumption elevate dopamine levels which control the brain's reward and pleasure centers in a way that is similar to many drugs of abuse including tobacco, cocaine and morphine. After long-term consumption, this leads to the opposite, a reduction in dopamine levels. This leads to higher consumption of sugar to get the same level of reward.
The found that FDA approved drugs like varenicline, a prescription medication trading as Champix which treats nicotine addiction, can work the same way when it comes to sugar cravings.
To the researcher's surprise, the study also found that artificial sweeteners could produce effects similar to those obtained with table sugar.
Vitamin C Lowers Cataract Risk
A diet rich in vitamin C could cut risk of cataract progression by a third, suggests a study published in a recent issue of Ophthalmology. The research is also the first to show that diet and lifestyle may play a greater role than genetics in cataract development and severity.
From more than 1,000 pairs of female twins analyzed, diets rich in vitamin C were associated with a 20 percent risk reduction for cataract. After 10 years, there was a 33 percent risk reduction of cataract progression.
Genetic factors accounted for 35 percent of the difference in cataract progression. Environmental factors, such as diet, accounted for 65 percent.
From more than 1,000 pairs of female twins analyzed, diets rich in vitamin C were associated with a 20 percent risk reduction for cataract. After 10 years, there was a 33 percent risk reduction of cataract progression.
Genetic factors accounted for 35 percent of the difference in cataract progression. Environmental factors, such as diet, accounted for 65 percent.
Friday, August 12, 2016
Extra safety for female joggers
Due to the recent tragic slayings of two NY joggers, it is more important than ever that runners take the necessary safety precautions when running/walking/hiking outdoors or on campus. These horrific events have people asking themselves "are we really safe when we run?"
SABRE, the world's number one pepper spray has released an athletic line of safety products to help deter danger. They have a Runner Personal Alarm with Adjustable Wrist Strap and their Runner Pepper Gel.
SABRE, the world's number one pepper spray has released an athletic line of safety products to help deter danger. They have a Runner Personal Alarm with Adjustable Wrist Strap and their Runner Pepper Gel.
Wednesday, August 10, 2016
Poison control centers are getting a surge of calls about ‘natural’ painkiller kratom
The herbal supplement seemed like a miracle. Trying to kick an opioid addiction, the middle-aged man found he could soothe his cravings with a tea made from an Asian plant called kratom. It relieved his pain and made him more alert.
But when he combined it with a stimulant, it also gave him a seizure that landed him in a Boston-area emergency room.
Those kinds of stories are on the rise, according to a study published Thursday in a weekly report from the Centers for Disease Control and Prevention. The number of calls to poison centers about problems stemming from kratom ingestion have increased tenfold over five years, from 26 in 2010 to 263 in 2015.
In many cases called into the poison control centers, the side effects of kratom were relatively mild: nausea, vomiting, drowsiness, and agitation. But there was one death, of a patient who took other drugs along with kratom. Other patients who took multiple substances suffered serious side effects — like the middle-aged Massachusetts man whose story was reported as a case study in the journal Addiction.
Kratom comes from the glossy leaves of a tree grown in the jungles of Southeast Asia. Traditionally, in countries like Thailand, the leaves have been crushed or brewed into tea and used as a painkiller or a replacement for opioids. That’s because a few of the chemicals in the leaf stimulate the same brain receptors as drugs like oxycodone and morphine.
Kratom is marketed as a natural herbal supplement, but it can be highly addictive. And clinicians and researchers worry about opioid users who try to wean themselves off drugs using kratom rather than seeking professional help.
“They want to turn their lives around, they want to get back on track, they turn to kratom,” said Oliver Grundmann, a pharmacologist at the University of Florida who was not involved in the report on poison control calls. “They take more and more and more, but it doesn’t do the job, and then they turn to heroin.”
Little is known about the exact workings of kratom on the brain, but it seems to function as a stimulant at low doses and a depressant at high doses, said Royal Law, an epidemiologist at the CDC and a coauthor of the study in the Morbidity and Mortality Weekly Report.
The new tally of poison center calls comes as kratom has emerged as a significant public health concern.
Six states have banned kratom, and others are considering restrictions, according to the website of the American Kratom Association. The Food and Drug Administration has banned its importation. But it is still widely available online, in tea or capsule form. Some researchers have even found packets of it sold in gas stations.
The Drug Enforcement Administration has classified kratom as a drug of concern, but that does not prevent its sale or use.
But when he combined it with a stimulant, it also gave him a seizure that landed him in a Boston-area emergency room.
Those kinds of stories are on the rise, according to a study published Thursday in a weekly report from the Centers for Disease Control and Prevention. The number of calls to poison centers about problems stemming from kratom ingestion have increased tenfold over five years, from 26 in 2010 to 263 in 2015.
In many cases called into the poison control centers, the side effects of kratom were relatively mild: nausea, vomiting, drowsiness, and agitation. But there was one death, of a patient who took other drugs along with kratom. Other patients who took multiple substances suffered serious side effects — like the middle-aged Massachusetts man whose story was reported as a case study in the journal Addiction.
Kratom comes from the glossy leaves of a tree grown in the jungles of Southeast Asia. Traditionally, in countries like Thailand, the leaves have been crushed or brewed into tea and used as a painkiller or a replacement for opioids. That’s because a few of the chemicals in the leaf stimulate the same brain receptors as drugs like oxycodone and morphine.
Kratom is marketed as a natural herbal supplement, but it can be highly addictive. And clinicians and researchers worry about opioid users who try to wean themselves off drugs using kratom rather than seeking professional help.
“They want to turn their lives around, they want to get back on track, they turn to kratom,” said Oliver Grundmann, a pharmacologist at the University of Florida who was not involved in the report on poison control calls. “They take more and more and more, but it doesn’t do the job, and then they turn to heroin.”
Little is known about the exact workings of kratom on the brain, but it seems to function as a stimulant at low doses and a depressant at high doses, said Royal Law, an epidemiologist at the CDC and a coauthor of the study in the Morbidity and Mortality Weekly Report.
The new tally of poison center calls comes as kratom has emerged as a significant public health concern.
Six states have banned kratom, and others are considering restrictions, according to the website of the American Kratom Association. The Food and Drug Administration has banned its importation. But it is still widely available online, in tea or capsule form. Some researchers have even found packets of it sold in gas stations.
The Drug Enforcement Administration has classified kratom as a drug of concern, but that does not prevent its sale or use.
Tuesday, August 09, 2016
Friday, August 05, 2016
Thursday, August 04, 2016
Carrageenan not toxic to intestinal cells: study
Carrageenan is a common food additive used for its gelling and thickening properties. It has become a controversial ingredient over the last five years.
A study in the upcoming October issue of Food and Chemical Toxicity examined the effects of carrageenan on cell permeability, cytotoxicity, and cytokine gene expression in human intestinal and hepatic cell lines.
Three common forms of the food additive carrageenan were tested in vitro.
The carrageenan tested were subjected to advanced identity and purity testing.
Carrageenan was evaluated in three human intestinal cell lines.
Endpoints included permeability, cytotoxicity, and induction of cytokines.
Carrageenan was negative in all endpoints evaluated.
In conclusion, carrageenan was not absorbed, and was not cytotoxic. It did not induce oxidative stress, and did not induce proinflammatory proteins.
A study in the upcoming October issue of Food and Chemical Toxicity examined the effects of carrageenan on cell permeability, cytotoxicity, and cytokine gene expression in human intestinal and hepatic cell lines.
Three common forms of the food additive carrageenan were tested in vitro.
The carrageenan tested were subjected to advanced identity and purity testing.
Carrageenan was evaluated in three human intestinal cell lines.
Endpoints included permeability, cytotoxicity, and induction of cytokines.
Carrageenan was negative in all endpoints evaluated.
In conclusion, carrageenan was not absorbed, and was not cytotoxic. It did not induce oxidative stress, and did not induce proinflammatory proteins.
Tuesday, August 02, 2016
Monday, August 01, 2016
Friday, July 29, 2016
Wednesday, July 27, 2016
Friday, July 22, 2016
Wednesday, July 20, 2016
Friday, July 15, 2016
Wednesday, July 13, 2016
Tuesday, July 12, 2016
Monday, July 11, 2016
Thursday, July 07, 2016
Dangerous Drug Combo
Thyroid Hormone and Proton Pump Inhibitors
Thyroid supplementation is extremely common. Some frequently used drugs, including proton pump inhibitors (PPIs), can interfere with thyroid hormone absorption, causing patients whose disease was previously well-controlled on a thyroid hormone to develop hypothyroidism.
The interaction between levothyroxine and omeprazole in patients with impaired gastric acid secretion requires an increased dose of oral thyroxine, which suggests that normal acid secretion is necessary for effective oral absorption of thyroxine. Patients with hypothyroidism who are euthyroid and on levothyroxine may need thyroid function testing after initiation of a PPI, especially if symptoms of hypothyroidism emerge. And those with impaired gastric acid secretion may require an increased dose of levothyroxine to keep the thyroid-stimulating hormone level within range.
The product labeling for levothyroxine recommends that it not be administered simultaneously. If concurrent use is necessary, administration of the agents should be separated by 4 hours.
Thyroid supplementation is extremely common. Some frequently used drugs, including proton pump inhibitors (PPIs), can interfere with thyroid hormone absorption, causing patients whose disease was previously well-controlled on a thyroid hormone to develop hypothyroidism.
The interaction between levothyroxine and omeprazole in patients with impaired gastric acid secretion requires an increased dose of oral thyroxine, which suggests that normal acid secretion is necessary for effective oral absorption of thyroxine. Patients with hypothyroidism who are euthyroid and on levothyroxine may need thyroid function testing after initiation of a PPI, especially if symptoms of hypothyroidism emerge. And those with impaired gastric acid secretion may require an increased dose of levothyroxine to keep the thyroid-stimulating hormone level within range.
The product labeling for levothyroxine recommends that it not be administered simultaneously. If concurrent use is necessary, administration of the agents should be separated by 4 hours.
Wednesday, July 06, 2016
Tuesday, July 05, 2016
Friday, July 01, 2016
Thursday, June 30, 2016
Thursday, June 23, 2016
Tuesday, June 21, 2016
Monday, June 20, 2016
Wednesday, June 15, 2016
WHO: coffee not carcinogenic, but protective
It's about time!
http://www.wsj.com/articles/world-health-organization-to-drop-coffees-status-as-possible-carcinogen-1465946753
http://well.blogs.nytimes.com/2016/06/15/coffee-may-protect-against-cancer-w-h-o-concludes/?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health®ion=rank&module=package&version=highlights&contentPlacement=1&pgtype=sectionfront&_r=0
http://www.wsj.com/articles/world-health-organization-to-drop-coffees-status-as-possible-carcinogen-1465946753
http://well.blogs.nytimes.com/2016/06/15/coffee-may-protect-against-cancer-w-h-o-concludes/?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health®ion=rank&module=package&version=highlights&contentPlacement=1&pgtype=sectionfront&_r=0
Thursday, June 09, 2016
Wednesday, June 08, 2016
Monday, June 06, 2016
Diet Inextricably Linked to Rheumatoid Arthritis
Your diet greatly influences your chances of developing rheumatoid arthritis. Two studies presented recently at the American College of Rheumatology annual meeting found those who ate a diet high in red and processed meat, refined grains, fried food, high-fat dairy and sweets were more likely to develop rheumatoid arthritis than those who ate a diet high in fruits, vegetables, legumes, whole grains, poultry and fish.
Surprisingly, the same research team found that even following the Dietary Guidelines for Americans can lower the risk of developing rheumatoid arthritis.
Rheumatoid arthritis, an autoimmune disorder, is characterized by pain, stiffness and swelling in multiple joints. The cause is unknown, and it can lead to joint damage and deformity. More women develop it than men.
Surprisingly, the same research team found that even following the Dietary Guidelines for Americans can lower the risk of developing rheumatoid arthritis.
Rheumatoid arthritis, an autoimmune disorder, is characterized by pain, stiffness and swelling in multiple joints. The cause is unknown, and it can lead to joint damage and deformity. More women develop it than men.
Friday, June 03, 2016
Tuesday, May 31, 2016
Friday, May 27, 2016
Thursday, May 26, 2016
Wednesday, May 25, 2016
FDA rules on evaporated cane juice
We completely agree with this ruling. Sugar is sugar no mater how you spin it label-wise.
FDA: "This guidance is intended to help consumers make informed choices among sweeteners by promoting accurate and consistent labeling. To that end, we are advising the regulated industry of our view that the term “evaporated cane juice” is not the common or usual name of any type of sweetener and that this ingredient should instead be declared on food labels as “sugar,” preceded by one or more truthful, non-misleading descriptors if the manufacturer so chooses (e.g., “cane sugar”)."
http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm181491.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
FDA: "This guidance is intended to help consumers make informed choices among sweeteners by promoting accurate and consistent labeling. To that end, we are advising the regulated industry of our view that the term “evaporated cane juice” is not the common or usual name of any type of sweetener and that this ingredient should instead be declared on food labels as “sugar,” preceded by one or more truthful, non-misleading descriptors if the manufacturer so chooses (e.g., “cane sugar”)."
http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm181491.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Tuesday, May 24, 2016
Thursday, May 19, 2016
Tuesday, May 17, 2016
Monday, May 16, 2016
Thursday, May 12, 2016
Wednesday, May 11, 2016
Wednesday, May 04, 2016
Subscribe to:
Posts (Atom)
